Vyne Therapeutics Inc. (VYNE)
NASDAQ · Healthcare
Vyne Therapeutics Inc. Revenue 2016–2025
Vyne Therapeutics Inc. annual/quarterly revenue history and growth rate from 2016 to 2026. Revenue can be defined as the amount of money a company receives from its customers in exchange for the sale of goods or services. Revenue is the top line item on an income statement from which all costs and expenses are subtracted to arrive at net income.
- Vyne Therapeutics Inc. revenue for the quarter ending March 31, 2026 was 86000, a 57.43% decrease year-over-year.
- Vyne Therapeutics Inc. revenue for the twelve months ending March 31, 2026 was 478000, a 12.29% decrease year-over-year.
- Vyne Therapeutics Inc. annual revenue for 2025 was 570000, a 13.77% increase from 2024.
- Vyne Therapeutics Inc. annual revenue for 2024 was 501000, a 18.16% increase from 2023.
- Vyne Therapeutics Inc. annual revenue for 2023 was 424000, a 11.11% decrease from 2022.
- Vyne Therapeutics Inc. annual revenue for 2022 was 477000.
Revenue
ANNUAL · $B
QUARTERLY · $B
YEAR-OVER-YEAR GROWTH · %
Vyne Therapeutics Inc. Earnings — FAQ
Vyne Therapeutics Inc. (VYNE) earnings over the last 10 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see VYNE's earnings history?
The chart and table above show Vyne Therapeutics Inc.'s earnings by year and by quarter, including the growth rate.